COVID-19Updates See latest Press Relases Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting 3 Jun 2024 8 Minutes 0 846 ... Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy 14 May 2024 8 Minutes 0 845 ... Celularity Inc. to Host Investor and Analyst Research & Development Day 22 Apr 2024 7 Minutes 0 836 ... Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 18 Apr 2024 9 Minutes 0 839 ... Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products 15 Apr 2024 10 Minutes 0 848 ... Load more
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting 3 Jun 2024 8 Minutes 0 846 ...
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy 14 May 2024 8 Minutes 0 845 ...
Celularity Inc. to Host Investor and Analyst Research & Development Day 22 Apr 2024 7 Minutes 0 836 ...
Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 18 Apr 2024 9 Minutes 0 839 ...
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products 15 Apr 2024 10 Minutes 0 848 ...